ANKARA, TURKEY — A strategy that takes advantage of the C in ICD (implantable cardioverter defibrillator), in which the device delivers a shock aimed at restoring sinus rhythm in patients with atrial ...

TURKU, FINLAND — Even if electrical cardioversion of atrial fibrillation (AF) is carried out without anticoagulation within 48 hours of acute-AF onset, the first 12 hours of that period provide by far ...

Endurance athletes may be at increased risk for lone atrial fibrillation. 1–5 We describe a middle-aged physician athlete with paroxysmal lone atrial fibrillation in whom cardioversion consistently ...

Cardioversion is a treatment for a relatively common heart condition called atrial fibrillation. Through this procedure, an abnormally fast or slow heart rate is converted to a normal rhythm with the ...

Please provide your email address to receive an email when new articles are posted on . Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among ...

Hubner and colleagues in the UK have recently described a simplified cardioversion service that has significantly reduced waiting times at their center. They have introduced intravenous midazolam ...

Pharmacological- and electrical-first cardioversion worked similarly well for treating acute atrial fibrillation (Afib) in the emergency department, according to the Canadian RAFF2 trial. The 204 ...

Please provide your email address to receive an email when new articles are posted on . PARIS — Cardioversion with maximum-fixed energy shocks was more effective than low-escalating energy shocks for ...

The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion.

Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...

Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...